L.-C. Campeau
Husband, father & leader @ #MerckChemistry. Trying to change the world, one reaction at a time. Learned many things, including love of Scotch from Keith Fagnou.
Last synced from Twitter 867d ago
For scientists’ working hours, what does ‘done’ mean?
“As long as you get your work done” can be a trap, our Experimental Error columnist writes
1
L.-C. Campeau
Conundrum is perfectly stated —> “The fact is that we don’t have a reliable way to gauge how productively a scientist works. And in the absence of such a metric [...] they should just kind of work as much as possible forever until they die.” /1
140d
NSERC - Media Room - Latest News - Reaffirming our values and commitment to equity, diversity and inclusion
NSERC - Media Room - Latest News - Reaffirming our values and commitment to equity, diversity and inclusion
1
L.-C. Campeau
NSERC’s statement condemning the Hudlicky article - Reaffirming our values and commitment to equity, diversity and inclusion
230d
Director, Chemical Biology
Click the link provided to see the complete job description.
Metal- and Acid-Free C–H Formylation of Nitrogen Heterocycles: Using Trioxane as an Aldehyde Equivalent Enabled by an Organic-Soluble Oxidant
Metal- and Acid-Free C–H Formylation of Nitrogen Heterocycles: Using Trioxane as an Aldehyde Equivalent Enabled by an Organic-Soluble Oxidant
Directed Cp*RhIII-Catalyzed Fluorosulfonylvinylation of Arenes
Directed Cp*RhIII-Catalyzed Fluorosulfonylvinylation of Arenes
Combining traditional 2D and modern physical organic-derived descriptors to predict enhanced enantioselectivity for the key aza-Michael conjugate addition in the synthesis of Prevymis™ (letermovir) - Chemical Science (RSC Publishing)
Quantitative structure–activity relationships have an extensive history for optimizing drug candidates, yet they have only recently been applied in reaction development. In this report, the predictive power of multivariate parameterization has been...
Computational Biologist
Click the link provided to see the complete job description.
Is Big Pharma really more evil than academia?
Richard P Grant: The pharmaceutical industry gets a bad press. Some of the criticism is surely deserved, but the widespread notion that academia is morally superior is ridiculous.
Terry Fox Run
Sunday Sept. 16, 2018
Everyone is welcome to participate in a Terry Fox Run, regardless of age, athletic ability or socio-economic standing. While the Run does not have an entry fee or minimum donation we do ask all participants to fundraise or...
In Defense of Hype
In the wake of scandal, it’s easy to dismiss every “world-changing” idea. But sometimes, those ideas actually will.
L.-C. Campeau
“Invention—as brilliant as it may be—dies without adoption. Adoption often fails without continued investment. Investment often follows vision. And vision needs to be shared and promoted…and, yes, sometimes hyped in order to find an audience...” #Truth
875d
The Big Lie
A professor schemed to get a raise and win his department’s respect. Instead he wrecked his career.
How Merck and Purdue have teamed up to solve measurement challenges
Focused on technology to improve drug manufacture and formulation, the year-old academic-industrial partnership benefits professors, students, and company scientists
L.-C. Campeau
Our Analytical Chemistry team highlighted for their collaboration with Purdue. #MerckChemistry
877d
Helping Protect Generations From Preventable Infectious Diseases
By: Michael Nally president, Merck Vaccines
FDA Approves Merck’s DELSTRIGO™ (doravirine / lamivudine / tenofovir disoproxil fumarate), a Once-Daily Fixed-Dose Combination Tablet as a Complete Regimen and PIFELTRO™ (doravirine), an NNRTI, Both for the Treatment of HIV-1 in Appropriate Patients
FDA Approves Merck’s DELSTRIGO and PIFELTRO, Both for the Treatment of HIV-1 in Appropriate Patients
FDA Approves Merck’s DELSTRIGO™ (doravirine / lamivudine / tenofovir disoproxil fumarate), a Once-Daily Fixed-Dose Combination Tablet as a Complete Regimen and PIFELTRO™ (doravirine), an NNRTI, Both for the Treatment of HIV-1 in Appropriate Patie
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S.
L.-C. Campeau
Really excited for this news! Very proud of having been part of this discovery while at Merck-Frosst! Congrats to @DrBanjoCrush and my old colleagues! #MerckChemistry
881d
Catalytic Alkene Difunctionalization via Imidate Radicals
Catalytic Alkene Difunctionalization via Imidate Radicals